Xiangdong Guo
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Metformin Sensitizes PTEN-deficient Prostate Cancer to PARP Inhibitors by Rebuilding NADP+ Homeostasis.
Journal: International journal of biological sciences
Published: July 05, 2025
PARP inhibitors restore NK cell function via secretory crosstalk with tumor cells in prostate cancer.
Journal: The Journal of clinical investigation
Published: June 23, 2025
The neuro-immune axis in cancer: from mechanisms to therapeutic opportunities.
Journal: Journal of hematology & oncology
Published: June 21, 2025
Anti-Müllerian hormone plays a bidirectional role in cancer: a multi-database and multi-method study.
Journal: Discover oncology
Published: February 23, 2025
Immunological synapse: structures, molecular mechanisms and therapeutic implications in disease.
Journal: Signal transduction and targeted therapy
Published: December 27, 2024
Cofilin1-driven cytoskeletal remodeling modulates pan-cancer CD8+ T cell immunotherapy responses.
Journal: Cell reports. Medicine
Published: November 04, 2024
Biomechanics in the tumor microenvironment: from biological functions to potential clinical applications.
Journal: Experimental hematology & oncology
Published: September 16, 2024
Machine learning based androgen receptor regulatory gene-related random forest survival model for precise treatment decision in prostate cancer.
Journal: Heliyon
Published: June 19, 2024
SLC7A5 correlated with malignancies and immunotherapy response in bladder cancer.
Journal: Cancer cell international
Published: February 23, 2024
Poly (ADP-ribose) Polymerase Inhibitors in Patients with Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials.
Journal: Medicina (Kaunas, Lithuania)
Published: October 19, 2023
Showing 1-11 of 11
Last Updated: 09/26/2026